Results 11 to 20 of about 4,273,082 (313)

Paternal and Maternal History of Myocardial Infarction and Cardiovascular Diseases Incidence in a Dutch Cohort of Middel-Aged Persons [PDF]

, 2011
Background - A positive parental history of myocardial infarction (MI) is an independent risk factor for cardiovascular diseases (CVD). However, different definitions of parental history have been used.
Jolanda M. A. Boer, Kromhout, D., Johanna M. Geleijnse, Verschuren W. M. Monique, Boer Jolanda M. A., Ineke van Dis, Dis, I., van, Geleijnse, J.M., Geleijnse Johanna M., Kromhout Daan, Boer, J.M.A., Verschuren, W.M.M., Daan Kromhout, van Dis Ineke, W. M. Monique Verschuren   +14 more
core   +1 more source

Testosterone and Cardiovascular Disease [PDF]

The Open Cardiovascular Medicine Journal, 2016
Cardiovascular disease [CVD] is a leading cause of mortality accounting for a global incidence of over 31%. Atherosclerosis is the primary pathophysiology underpinning most types of CVD. Historically, modifiable and non-modifiable risk factors were suggested to precipitate CVD.
Tambo, Amos, Roshan, Mohsin H.K., Pace, Nikolai Paul   +2 more
openaire   +3 more sources

Quality of life status determinants in hypertrophic cardiomyopathy as evaluated by the Kansas City Cardiomyopathy Questionnaire

Health and Quality of Life Outcomes, 2020
Purpose The present study evaluated how heart failure (HF) negatively impacts health-related quality of life (HRQoL) in hypertrophic cardiomyopathy (HCM) patients and explored the major clinical determinants associated with HRQoL impairment in this ...
Razvan Capota, Sebastian Militaru, Alin Alexandru Ionescu, Monica Rosca, Cristian Baicus, Bogdan Alexandru Popescu, Ruxandra Jurcut   +6 more
doaj   +1 more source

Lipoprotein(a) in Cardiovascular Diseases [PDF]

BioMed Research International, 2013
Lipoprotein(a) (Lp(a)) is an LDL-like molecule consisting of an apolipoprotein B-100 (apo(B-100)) particle attached by a disulphide bridge to apo(a). Many observations have pointed out that Lp(a) levels may be a risk factor for cardiovascular diseases.
Malaguarnera M, Vacante M, Russo C, Malaguarnera G, Antic T, MALAGUARNERA, Lucia, BELLA, Rita, PENNISI, Giovanni, GALVANO, Fabio, Frigiola A.   +9 more
openaire   +3 more sources

Cutaneous-Pericardial Fistula: Rare Complication of Transapical Aortic Valve Replacement—Case Report and Literature Review

Case Reports in Surgery, 2020
Cutaneous-pericardial fistula is a rare complication of transapical aortic valve replacement; only a few cases are reported in the literature. It is part of a wide range of surgical site infection manifestations that could emerge after surgery.
Andrei Tarus, Mihail Enache, Igor Nedelciuc, Iulian Rotaru, Alberto Emanuel Bacusca, Grigore Tinica   +5 more
doaj   +1 more source

Safety and tolerability of Sacubitril/Valsartan in heart failure patient with reduced ejection fraction

BMC Cardiovascular Disorders, 2023
Background Angiotensin receptor blocker and a neprilysin inhibitor (ARNI) has emerged as an innovative therapy for patients of heart failure with reduced ejection fraction (HFrEF).
Muhammad Nauman Khan, Najia Aslam Soomro, Khalid Naseeb, Usman Hanif Bhatti, Rubina Rauf, Iram Jehan Balouch, Ali Moazzam, Sonia Bashir, Tariq Ashraf, Musa Karim   +9 more
doaj   +1 more source

Topological Data Analysis Identified Prognostically-Distinct Phenotypes in Transcatheter Edge-to-Edge Repair Patients

Mayo Clinic Proceedings: Digital Health, 2023
Objective: To identify prognostically distinct phenotype clusters in transcatheter edge-to-edge repair (TEER) patients based on topological data analysis (TDA), which was never used to assess the heterogeneous TEER population.
Chieh-Ju Chao, MD, Timothy Barry, MB, BCh, BAO, Amith Seri, MBBS, Ahmed El Shaer, MBBS, Nadia Chavez Ponce, MD, Soham Chakraborty, BS, Sean Smith, MD, Mohamad Alkhouli, MD, Jeremy Thaden, MD, David Fortuin, MD, John P. Sweeney, MD, Mackram Eleid, MD, Charanjit S. Rihal, MD, David R. Holmes, MD, Peter M. Pollak, MD, Abdallah El Sabbagh, MD, Steven J. Lester, MD, Jae K. Oh, MD, Win-Kuang Shen, MD, Imon Banerjee, PhD, Reza Arsanjani, MD   +20 more
doaj   +1 more source

Epicardial fat links obesity to cardiovascular diseases

, 2023
Patients with obesity have been historically associated with higher risk to develop cardiovascular diseases (CVD). However, regional, visceral, organ specific adiposity seems to play a stronger role in the development of those cardiovascular diseases ...
Iacobellis, Gianluca, Gianluca Iacobellis   +1 more
core   +1 more source

Obesity and Cardiovascular Disease [PDF]

Circulation Research, 2016
The prevalence of obesity has increased worldwide over the past few decades. In 2013, the prevalence of obesity exceeded the 50% of the adult population in some countries from Oceania, North Africa, and Middle East. Lower but still alarmingly high prevalence was observed in North America (≈30%) and in Western Europe (≈20%). These figures are of serious
Ortega, Francisco B., Lavie, Carl J., Blair, Steven N.   +2 more
openaire   +5 more sources

Oral health as a modifiable risk factor for cardiovascular diseases [PDF]

, 2023
: Cardiovascular diseases (CVDs) are a leading cause of morbidity and mortality worldwide with a high socioeconomic burden. Increasing evidence supports a convincing connection with increased cardiovascular risk of periodontal diseases (PD), a group of ...
Pietropaoli D., Ferri C., Del Pinto R., Altamura S.   +3 more
core   +1 more source